Jeannie M. Boettler

Experience

Jeannie advises on patentable matters relating to DNA, RNA, proteins, gene therapy, antibodies, biologics, pharmaceuticals, drug delivery, drug conjugates, medical and research diagnostic assays, biomarkers, molecular cloning, protein expression, cell culture and development, immunohistochemistry, transgenic oils, transgenic plants, biofuels, nanotechnology, microfluidics, skin science, absorbent materials, food science, adult and pediatric nutritionals and microencapsulation.

Other subject areas within her purview include solar panels, electrochemical cells, hydrogen generator cells and fuel cells.

Jeannie guides clients in post grant proceedings including Inter Partes Review and Post Grant Review.

She counsels on patent and FDA strategy under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) and the Biologics Price Competition and Innovation Act of 2009.

Devoted to advancing and protecting scientific advances in life sciences, Jeannie frequently presents and writes for legal, business and industry organizations.

News

Speaking Engagements

Co-Presenter, "Intellectual Property and the Juvenile Products Industry," JPMA Baby Show, March 2018

Co-Presenter "Caveat Emptor: The Need to Conduct IP Due Diligence," Association of Corporate Counsel St. Louis Chapter CLE, June 2017

Co-Presenter, "Tips and Tricks for Addressing U.S. Patent Eligibility," Roche Diagnostics Operations, Indianapolis, IN, April 2015

"USPTO Interim Guidance on Patent Eligibility," Minnesota CLE, March 2015

Co-Presenter, "Implications of Post Grant Proceedings for Universities," Indiana University Research and Technology Corp., Indianapolis, IN, August 2014

Co-Presenter, "Roche IP Academy; Examiner Interviews, Patent Term Adjustment Update, and United States Supreme Court – 2014 Patent Cases," Roche Diagnostics Operations, Indianapolis, IN, February 2014

Publications

Peer Reviewer, Pharmaceutical Patent Analyst